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Available online 21 February 2016Quantitative measurement of localized longitudinal changes in brain abnormalities at an individual level may
offer critical information for disease diagnosis and treatment. The voxel-wise permutation-based method
SPREAD/iSPREAD,which combines resampling and spatial regression of neighboring voxels, provides an effective
and robust method for detecting subject-speciﬁc longitudinal changeswithin thewhole brain, especially for lon-
gitudinal studies with a limited number of scans. As an extension of SPREAD/iSPREAD, we present a general
method that facilitates analysis of serial Diffusion Tensor Imaging (DTI) measurements (with more than two
time points) for testing localized changes in longitudinal studies. Two types of voxel-level test statistics
(model-free test statistics, which measure intra-subject variability across time, and test statistics based on gen-
eral linear model that incorporate speciﬁc lesion evolution models) were estimated and tested against the null
hypothesis among groups of DTI data across time. The implementation and utility of the proposed statistical
method were demonstrated by both Monte Carlo simulations and applications on clinical DTI data from
human brain in vivo. By a design of test statistics based on the disease progression model, it was possible to ap-
portion the true signiﬁcant voxels attributed to the disease progression and those caused by underlying anatom-
ical differences that cannot be explained by themodel, which led to improvement in false positive (FP) control in
the results. Extension of the proposed method to include other diseases or drug effect models, as well as the fea-
sibility of global statistics, was discussed. The proposed statisticalmethod can be extended to a broad spectrumof
longitudinal studies with carefully designed test statistics, which helps to detect localized changes at the individ-
ual level.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Longitudinal study1. Introduction
Diffusion Tensor Imaging (DTI) (Le Bihan et al., 2001; Tournier et al.,
2011), which measures the random motion of water molecules, pro-
vides a non-invasive way to investigate the structural integrity of the
brain. It has been widely used in investigating white matter (WM)
changes caused by brain development and aging (Westlye et al.,
2009), detecting abnormalities in normal-appearingWMdue to disease
(Weiner et al., 2000), as well as identifying pathologic severity inhester Center for AIDS Research
iences, University of Rochester,
8, United States.
).
. This is an open access article underpatients with MS (Werring et al., 1999). In recent years, there has
been increasing interest in the investigation of subject-speciﬁc changes
within the brain without prior information regarding the spatial distri-
bution of the pathology. Consequently, whole brain voxel-based
methods (Ashburner and Friston, 2000; Smith et al., 2006; Tustison
et al., 2014) have gained much favor during recent years as an impor-
tant alternative to region of interest (ROI) analysis in detecting localized
changes within the brain and are most suitable when changes/effects
are diffuse among individual subjects. Both parametric and nonpara-
metric methods have been used to help identify regionally speciﬁc
changes such as differences due to activation in fMRI (Nichols and
Holmes, 2002), neuroanatomical differences in structure MRI data
(Bullmore et al., 1999) and pathophysiology in longitudinal studies
(Zhu et al., 2013; Chung et al., 2008).
Due to the non-Gaussian nature of DTI data, nonparametric voxel-
based methods that do not need any parametric assumptions such asthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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permutation-based methods (Nichols and Holmes, 2002), are more
suitable. The nonparametric permutation-based method is able to de-
vise a data-driven null distribution with only minimal assumptions,
which gives the user more freedom in devising test statistics of interest.
Any sensible test statistic that summarizes the local effect can be used in
these hypothesis-testing procedures and the strong control of type I
error is guaranteed under very mild assumptions of the null distribu-
tion. Such methods have been widely used in the area of fMRI to inves-
tigate the regionally speciﬁc effect in neuroimaging data (Nichols and
Holmes, 2002). However, few of the aforementioned methods have
been applied to subject-speciﬁc longitudinal studies. This is mainly be-
cause the number of available scans in a longitudinal study is often lim-
ited by practical factors such as the cost of patient recruitment, and the
obtained data lacks sufﬁcient information for a rigorous statistical infer-
ence test due to their low degrees of freedom.
The Spatial Regression Analysis of Diffusion tensor imaging
(SPREAD) method previously presented (Zhu et al., 2013) combines
spatial regression and resampling methods, which provides a novel
and efﬁcientwhole brain analysismethod for detecting localized chang-
es in subject-speciﬁc longitudinal study without an a priori hypothesis,
for DTI-derivedmetrics such as fractional anisotropy (FA) andmean dif-
fusivity (MD). SPREAD requires only one scan per time point for a valid
statistical inferential test, which greatly reduces the granularity of per-
mutation. The iSPREAD method (Liu et al., in press) further improves
the detection sensitivity and accuracy of SPREAD (Zhu et al., 2013) sub-
stantially by incorporating a three-dimensional (3D) nonlinear aniso-
tropic diffusion ﬁltering method. Both SPREAD and iSPREAD utilize a
novel and effective permutation-based statistical method for whole
brain analysis that relies on permuting time/scan labels and spatial ker-
nel regression. They donot require adjustment of signal gains due to dif-
ferent DTI protocols at different time points and are effective for
monitoring subject-speciﬁc lesion progression in longitudinal studies.
However, aside from their many advantages, the following limitations
exist for SPREAD/iSPREAD, which are also general to most
permutation-based voxel-wise subject-speciﬁc methods applied in lon-
gitudinal studies:
1) The comparison is often taken pairwise between each time point vs.
baseline, which is time consuming in the presence of serial DTI stud-
ies with multiple time points.
2) The potential differences caused by registration error or anatomical
differences due to atrophic changes may manifest as false-positive
voxels in the results. The consequences for such misalignment can
either falsely identify positives or neglect true positives, both of
which greatly reduce the statistical power and reliability of the re-
sults obtained.
3) The apparent and useful prior information of lesion progression
models is largely neglected in these existing methods.
Therefore, a general statistical framework that accommodates a seri-
al DTI study with multiple time points while taking into consideration
the speciﬁc disease progression model is desired.
The main purpose of many longitudinal studies is to identify local-
ized temporal changes within the brain. One crucial step towards de-
tecting localized changes is to choose test statistics that are likely to be
the most sensitive and informative in depicting possible departures
from the null hypothesis, which assumes that there is no difference be-
tween data obtained at different timepoints. The statistical properties of
any given hypothesis-testing procedure depend on both the null hy-
pothesis, which speciﬁes the distributional properties of the measure-
ments without true signal, and the alternative hypothesis, which
speciﬁes the possible forms of true signal (temporal changes, in this
case). The non-parametric permutation-based methods, such as
SPREAD/iSPREAD, permit the use of a wide range of test statistics with-
out the need to derive closed-formdistributions of these statistics under
the null hypothesis with speciﬁc parametric assumptions. Thisﬂexibility enables us to focus on choosing the optimum statistics
based on different alternative hypotheses.
In this study, we proposed to extend the current SPREAD/iSPREAD
method to a general statistical framework that accommodates a wide
range of alternative hypotheses used in longitudinal studies. Five test
statistics, which were divided into two major types, were implemented
in the current statistical framework to help identify several different
forms of temporal changes within individual subjects. One type is
based on model-free test statistics; another is based on a general linear
model that incorporates a certain disease evolution model. Our statisti-
cal method is similar in spirit to twowell-establishedmethods in statis-
tical parametric maps (SPM) for assessing the regionally speciﬁc effects
within the brain, namely the subtractive method (Worsley et al., 1992,
1996) and the general linear model (Friston et al., 1994), both of
which have been widely used in the fMRI ﬁeld for detection of brain ac-
tivation.Weuse those theorieswithin a nonparametric frameworkwith
carefully designed test statistics where the empirical null distribution is
generated by permutation.
The aim of the present study was to describe and illustrate a statisti-
cal method that enables the investigation of longitudinal changes quan-
titatively. Simulation data with a predeﬁned region of pathology and
disease effects were used to evaluate the effectiveness of the proposed
method. A series of DTI scans in three patients suffering from
relapsing-remitting multiple sclerosis (RRMS) were used as human
brain in vivo examples to demonstrate the implementation and utility
of this method. Both simulations and in vivo results show that the pro-
posedmethod is able to detect temporal changes in serial DTI with high
sensitivity and accuracy. Extension of the proposed statistical frame-
work to include other disease evolution/drug effect models as well as
different global statistics is discussed. The method is an extension of
SPREAD/iSPREAD, as well as an independent statistical framework that
can be easily applied to a wide variety of longitudinal studies.
2. Material and methods
2.1. Overview of iSPREAD for serial DTI analysis
Based on the exchangeability of the time and scan labels under the
null hypothesis (Zhu et al., 2013), in the ﬁrst step of iSPREAD analysis,
the scan/time labels for FA/MD maps from each subject are randomly
permuted at each voxel for N=1000 times to generate a permutation
distribution under the null hypothesis at each voxel. The permutated
images are then smoothed using the nonlinear anisotropic ﬁltering
method for edge-preserving image enhancement, aswell as for preserv-
ing spatial correlation between neighboring voxels. In the third step,
various voxel test statistics are chosen to depict the temporal changes
in a serial DTI analysis andwill be discussed in detail in the next section.
The Westfall-Young procedure (Nichols and Hayasaka, 2003) is used to
control the FWER in the last step. Voxels are identiﬁed as signiﬁcantly
changing (i.e. lesion areas) if their p-value is less than a predeﬁned p-
value (e.g. 0.05). The ﬂowchart of the proposed framework is shown
in Fig. 1.
2.1.1. The anisotropic diffusion ﬁlter
Nonlinear anisotropic diffusion ﬁltering provides a general scale-
space approach for edge-preservingpiecewise smoothing of the original
image. The nonlinear scale space generated by nonlinear diffusion ﬁlter-
ing is proposed from an analogy to thermal equations that describe the
diffusion process. The Perona-Malik (PM) (Perona and Malik, 1990)
equation for the process is shown in Eq. (1):
∂tI z;~t
  ¼ div g z;~t   ∇I z;~t  ; ð1Þ
where function Iðz;~tÞ is taken as the image intensity (e.g. FA or MDmap
in our study), and~t is the discrete cases. The conductance functiongðz;~tÞ
Fig. 1. Flow diagram of iSPREAD for serial DTI analysis.
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ent (j∇Iðz;~tÞÞj) given by Eq. (2):
g ¼ 1
1þ ∇I z;~tð Þj jκ
 2 ; ð2Þ
where |∇I | is taken as rough edge detector and κ is the diffusion contrast
parameter. The ratio j∇Iðx;tÞjκ controls the ﬂow strength. The maximum
ﬂow,∂tI(z, t), is obtained when gradient |∇I |=κ , which represents in-
homogeneous regions, and reduces to 0 when |∇I |≫κ or |∇I |≪κ,
which represents either potential edges or homogeneous regions. In
general, the nonlinear anisotropic ﬁltering method chooses intra-
region smoothing over inter-region smoothing.
The proper selection of the integration constant guarantees a stable
evolution of the PM equation and is given by Gerig et al. (1992) as
Eq. (3):
Δt≤
1
1þ
XN
i¼1
1
Δdið Þ2
; ð3Þ
where N is the number of nearest neighbors (N=26 in a 3D case), and
Δdi is the distance between the centroid and its neighboring voxels.
2.2. Statistical models for voxel-based test statistics
Two types of voxel-wise test statistics (ﬁve test statistics in total) are
used to detect temporal changes due to disease evolution in longitudi-
nal studies. The ﬁrst type (Test Statistics MF1 and MF2) uses intra-
subject variation, which is a natural extension of SPREAD/iSPREAD
from a pairwise group comparison for two time points to a multiple
group comparison for longitudinal studies that include multiple time
points. The second type (Test Statistics LM, QM1, and QM2) is based
on a general linear model for an across-time regression analysis. Other
test statistics can also be used in longitudinal studies based upon specif-
ic needs.
The following models were used to depict the lesion evolution over
time: (i) Simple linearmodel, which assumes that FA/MD changes by an
amount equal to the regression coefﬁcient over time; (ii) Quadratic
model (second-order polynomial model), which assumes a nonlinear
relationship over time.2.2.1. Model-free voxel-wise test statistic
This model-free test statistic detects intra-subject variation across
time. In the following, FA is used as an example, but similar analysis
also applies to MD.
ΔFAi ¼ σ n̂ ::i; ð4Þ
where σ ̂n ::1 can take one of the following two forms:
σ n̂ ::i ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1
T−1
XtT
t¼t1 FAn:ti−FAn ::i
 2r
Test Statistic MF1ð Þ; ð5Þ
σ n̂ ::i ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1
T−1
XtT
t¼t1 FAn:ti−FAn:t1 i
 2r
Test Statistic MF2ð Þ; ð6Þ
where FAnsti is the nth subject's sth scan at time t measured for the ith
voxel (n=1,2,… ,N ,s=1,2,… ,S , i=1,2,… , I ,t=t1,t2,… ,tT), FAn:ti ¼
1
S∑
S
s¼1FAnsti is the scan average and FAn ::i ¼ 1T∑
S
s¼1FAn:ti is the time av-
erage for each subject respectively, and FAn:t1 i is the FA map at baseline
(t=t1). There are twoways to select the baseline image: (i)with Test Sta-
tistic MF1 use the mean image of all time points as the baseline image
(Eq. (5)); (ii) with Test Statistic MF2 choose the image at the ﬁrst time
point as the baseline image (Eq. (6)). Both test statistics represent local-
ized temporal variation for FA/MD images at each voxel.
2.2.2. Voxel-wise statistics based on general linear model
All linear regressionmodels for a response variable Yij (e.g. FA/MD at
certain time point) at voxel j=1,… J can be expressed in general form
(Dobson and Barnett, 2011), where a linear model with correlated er-
rors is ﬁtted for each individual voxel time-series Yij. The standard gen-
eral linear model for an across-time regression analysis is shown as
Eq. (7)
Yij ¼ β0 þ β1xi1 þ β2xi2 þ⋯þ βKxiK þ ϵij; ð7Þ
where i=1,… I indexes the observation (e.g. scans at different time
points), ϵij is the error terms, and βk are kth unknown parameters for
each voxel j. The response variable Y at voxel j=1,… , J is expressed
as a linear combination of explanatory variables xik representing the
conditions under which observation i was made. In a longitudinal
study, xik is typically time; however, the explanatory variablesmight in-
clude covariates (e.g. age) or dummyvariables (e.g. gender, drug type or
dosage).
Fig. 2. Illustration of linear and quadratic simulated models (Effect size on λ1 vs. Timepoints).
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et al., 2006)were considered: a simple linearmodel (Eq. (8)) and a qua-
dratic model (Eq. (9)):
Yij ¼ β0 þ β1ti þ ϵij; ð8Þ
Yij ¼ β0 þ β1ti þ β2ti2 þ ϵij: ð9Þ
In both cases, the explanatory variable ti is time (in months) and the
dependent variable yij is the FA/MDvalue at jth voxelwithwhich the ob-
servation i (scan at the ith timepoint) ismade. Eq. (8) can be considered
as a special case of Nichols and Holmes (2002), in which β2=0, namely
the quadratic term vanishes. Together Eqs. (8) and (9) are useful inFig. 3.ROC analysis for group comparisons using iSPREADwithﬁveproposed test statistics to ide
simulated by either (a, b) a simple linear model (es1=0, es2=0.03, es3=0.05, es4=0.08, es
Sample sizes of n=3 and n=5 were considered. The disease area was simulated as a 5×5×3
calculated using Eq. (16). Results for FA analysis are shown here as an example.representing a large variety of realistic FA/MD changes over time in lon-
gitudinal studies.
The analysis of variance (ANOVA) F-test for the overall effect and t-
test for individual covariates are the two main hypothesis-testing
tools for multiple linear regressions. They can be used to generate the
per-voxel t- or F-statistic map and check the signiﬁcance of a linear as-
sociation under the assumption that themeasurement error is normally
distributed. Both t- and F-statistic can be viewed as signal-to-noise ra-
tios in which the denominators serve as a clever way to eliminate the
unknown nuisance parameter σε2, the variance of the measurement er-
rors. In the case of permutation-based statistical methods, the distribu-
tion of measurement errors under the null hypothesis is simulated from
a resampling procedure thus it is unnecessary to resort to division tontify localized changes fromMonte Carlo simulated data. Disease progressionmodelswere
5=0.15 ) or (c, d) a quadraticmodel (es1=0, es2=0.5, es3=0.2, es4=0.1, es5=0.05).
cubic region at the center of splenium corpus callosum. Sensitivity and Speciﬁcity were
Fig. 4. This patient had an active lesion (red arrows) in the posterior limb of the right internal capsule visible on the post contrast T1 images at baseline and resolved in the follow-up scans.
The degree of hyperintensity within the lesion lessened after 3 month and 4 month compared to the baseline scan.
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ing test statistics were chosen in our study.
1) Simple linear regression
The statement for the hypotheses:
H0 : β1 ¼ 0; versus H1 : β1≠0: ð10Þ
The permutation test is carried out using the following statistic:
β ̂1
			 			 Test Statistic LMð Þ; ð11ÞFig. 5. Comparison of signiﬁcant voxels detected for FA (magenta dots) using iSPREADwith ﬁve
time points were drawn in (b), together with a ﬁtted simple linear model and a quadratic regrwhere β ̂1 is the estimated slope value based on the standard least-
squares principle. The larger this value is, the stronger the evidence to
reject H0.
2) Quadratic regression
If only the coefﬁcient for the quadratic term (nonlinearity) is of in-
terest, the statement for the hypotheses is:
H0 : β2 ¼ 0; versus H1 : β2≠0: ð12Þproposed test statistics (a). Mean FA values calculated from gold standard ROIs at different
ession model for mean FAs over time.
Table 3
TPRL and FPRNLWM calculated using each test statistic on the ﬁrst slice of MS Patient 3.
Test statistics MF1 MF2 LM
TPRL 90.71% 90.71% 82.86%
FPRNLWM 2.31% 2.35% 1.81%
Table 1
TPRL and FPRNLWM calculated using each test statistic for MS patient 1.
Test statistics MF1 MF2 LM QM1 QM2
TPRL 88.01% 97.62% 83.33% 83.33% 88.10%
FPRNLWM 0.017% 0.30% 0.003% 0.004% 0.02%
296 B. Liu et al. / NeuroImage: Clinical 11 (2016) 291–301The permutation test is carried out using the following:
β ̂2
			 			 Test Statistic QM1ð Þ; ð13Þ
where β ̂2 is the estimated regression coefﬁcient for the quadratic term
using standard least square estimates.
If the signiﬁcance of the whole regression model is of interest, the
statement for the hypotheses:
H0 : β j ¼ 0; versus H1 : β j≠0; for j ¼ 1;2: ð14Þ
The permutation test is carried out using the following:
var ŷð Þ Test Statistic QM2ð Þ; ð15Þ
where ŷ ¼β ̂0þβ ̂1tiþβ ̂2ti2 is the ﬁtted value and varðŷÞ ¼
∑Ni¼1ðy
̂
− y ̅̂Þ2=N−1 is the variance of the ﬁtted value ŷ.
The ﬁve test statistics mentioned above were calculated at each
voxel to form the statistic images. Permutation and spatial regression
were used to construct the null distribution of these statistic images.
Signiﬁcant voxels were identiﬁed by comparing the original (un-per-
muted) statistic images to their permutation counterparts. Because all
ﬁve test statistics are larger under H1, the permutation p-value at a
given voxel is deﬁned as the proportion of permutation-generated test
statistic that is larger than the un-permuted version. We then applied
a suitablemultiple testing procedure such as theWestfall-Young proce-
dure (Westfall and Young, 1993) and the Benjamini Hochberg proce-
dure (Benjamini and Hochberg, 1995) to these p-value maps to
control for familywise error rate and false discovery rate, respectively.
Technical details about the resampling procedure and multiple testing
adjustments can be found in (Zhu et al., 2013).
2.3. Monte Carlo simulation
Effectiveness and statistical power of the proposed method were
ﬁrst validated by a Monte Carlo (MC) simulation of group comparisons
of repeated measurements of the same subject with a predeﬁned simu-
lateddisease area in serial DTIs. Simulationswere performed in a similar
manner as previously described in Zhu et al. (2013). Instead of
performing a two-group comparison, a multiple-group comparison
was simulated to mimic the disease progression in a longitudinal
study. Lesions were simulated as a 5×5×3 cubic region at the center
of the splenum corpus callosum with different effect sizes (es) of the
largest DTI eigenvalue (λ1) added in each voxel to imitate a real brain
abnormality. Values of es ranged from10–50%. Repeatedmeasurements
of the same subject were simulated by adding Gaussian-distributed
noise to both DTIpre and DTIpost templates to achieve signal-to-noise
ratio (SNR)≈50 in non-diffusion weighted images. The effect of ther-
mal noise was ﬁrst generated using complex random numbers withTable 2
TPRL and FPRNLWM calculated using each test statistic for MS patient 2.
Test statistics MF1 MF2 LM QM1 QM2
TPRL 85.06% 96.10% 75.65% 69.16% 77.92%
FPRNLWM 0.14% 4.50% 0.07% 0.06% 0.09%their real and imaginary parts sampled independently from a Gaussian
distribution function with a mean of zero and a standard deviation de-
termined by the desired SNR level (Andersen, 1996; Gudbjartsson and
Patz, 1995); the real parts of the complex noise signals were then
added to the noise-free baseline signal S0 and DW signals Si. Themagni-
tude of theﬁnal complex datawas then used to synthesize the noisy DTI
datasets that were further used for calculations of the noisy tensors. The
magnitude of DTIpre and DTIpost templates were then calculated from
the envelope of the complex signals. Numbers of repeated measure-
ments were chosen from n=2–5 for each group in the simulation,
and a total of 100 simulations were generated for each combination of
es and n.
Both a linear trend and a nonlinear trend of disease progression
models over time were considered, two models (Effect size on λ1 vs.
Timepoints) are illustrated in Fig. 2. The linear and nonlinear trends
on the largest eigenvalue λ1 also led to linear and nonlinear trends on
tensor-derived parameters such as FA/MD.
(i) Simple linear model: implies that white matter changes by an
amount equal to the regression coefﬁcient over time. This type
of model in a longitudinal study requires at least three time
points. For MC simulation, the following effect sizes were chosen
at each time point to mimic a linear relationship across
time: es1=0, es2=0.02, es3=0.05, es4=0.08, es5=0.15.
(ii) Quadratic model: implies a nonlinear relationship across time.
This type of model in a longitudinal study requires at least four
time points. For MC simulation, following effect sizes were cho-
sen at each time point to mimic a nonlinear relationship across
time: es1=0, es2=0.5 ,es3=0.2 ,es4=0.1 ,es5=0.05, which
represent different stages of the disease such as onset, peak and
recovery.
Group comparisons were conducted using iSPREAD with the ﬁve
proposed voxel-wise test statistics. True Positive Runs (TP_Runs) are
deﬁned as the total number of simulations within which at least one
voxel was correctly detected in the disease region. False Positive Runs
(FP_Runs) are deﬁned as the total number of simulations within
which at least one voxel was incorrectly detected in the non-disease re-
gion. Sensitivity and Speciﬁcity values are deﬁned based on TP_Runs
and FP_Runs as follows:
Sensitivity ¼ TP Runs
Total Simulation Runs
Specificity ¼ 1− FP Runs
Total Simulation Runs
;
ð16Þ
ROC curves were drawn by selecting the per-voxel p value from
0.01 to 0.3 with a gradual increment of 0.01. Results were compared be-
tween the ﬁve proposed test statistics.Table 4
TPRL and FPRNLWM calculated using each test statistic on the second slice of MS Patient 3.
Test statistics MF1 MF2 LM
TPRL 94.09% 94.09% 91.40%
FPRNLWM 2.31% 2.35% 1.81%
Fig. 6. This patient had an active lesion around the atrium of the left lateral ventricle visible on the post contrast T1 images at 6 month (red arrows) from baseline and resolved later.
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2.4.1. Subjects and image acquisition
Multiple sclerosis (MS) is an inﬂammatory disease of the central
nervous system that is thought to be a cell-mediated autoimmune dis-
ease leading to progressive neurologic dysfunction; it is classiﬁed into
different categories that include relapsing remitting, progressive, and
stable (Weiner et al., 2000). Relapsing-remitting MS (RRMS) is charac-
terized by clearly deﬁned occurrence of symptoms followed by the re-
mission of symptoms.
In our study, three RRMS patients (2 male and 1 female, mean
age 42±2) from an ongoing longitudinal MS study were used as sub-
jects. All subjects were given written informed consent and datasets
were acquired using protocols approved by the local institutional re-
view board.
Patientswere scanned at baseline and every 3 to 6months afterward
for a duration of 2 years. Images were acquired using a GE HDX 3T scan-
ner (Milwaukee, WI, USA). The Magnetic Resonance (MR) protocol
consisted of: (1) a T2 FLAIR scan; (2) a T1 contrast enhanced scan;
(3) a high resolution T1 SPGR scan, and (4) a DTI scan. Single-shot
echo planar diffusion-weighted imaging (SS-EPI) was acquired
with the following parameters:TR/TE=10500/82 ms; FOV=
240×240 mm2; acquisition matrix=128×128, zero-ﬁlled to matrix
size = 256×256; slice thickness 3 mm with no gap; 24 DWIs with
b=1000 s/mm2 and 4b0s with no diffusion weighting. Both the axial
T2 FLAIR and T1 contrast enhanced scans with resolution
2×2×3 mm3 were used for anatomic deﬁnition in the examination.2.4.2. Analysis
The data were analyzed using MATLAB (MATLAB 2013b, The
Mathworks, Natick, MA, USA) and FSL (FSL5.0.4, FMRIB Analysis
Group, Oxford University, Oxford, UK). The FSL package's eddy_correct
tool was used to correct eddy current and motion-induced artifacts in
the DTI data. The non-brain tissues were deleted using the BET tool in`Fig. 7. Signiﬁcant voxels detected for FA (marked by magenta dots) using iSPREADwith ﬁve pr
listed in Table 2.FSL; FA and MD maps were generated subsequently using DTIFIT tool
in FSL. To facilitate the voxel-wise comparison at each time point, FA/
MDmaps at later time points were ﬁrst co-registered to the FA/MD im-
ages at baseline using the FNIRT tool in FSL. The co-registered FA/MD
maps were then averaged, and these averaged maps were used as the
subject-speciﬁc templates to avoid asymmetry-induced bias in image
processing (Reuter and Fischl, 2011). The FA/MD maps at different
time points were then registered to the template using the FLIRT tool
of FSL. The ﬁnal co-registered FA/MD maps were used for the iSPREAD
analysis.
For each subject, the scan and time labels were randomly permuted
at each and every voxel for N=1000 times to generate the permutation
distribution under null hypothesis. Five voxel test statistics proposed
above were used tomodel changes in FA/MD over time. For the general
linearmodel, both simple linear and quadraticﬁtswere used to describe
the lesion progression over time using FA/MD values as the dependent
variable. The Westfall-Young method (Nichols and Hayasaka, 2003)
was used to control the FWER. Both True Positive Ratio in lesions
(TPRL) and False Positive Ratios in non-lesion white matter (FPRNLWM)
were calculated for each test statistics to quantify the sensitivity and
speciﬁcity in lesion detection, which were deﬁned as in Eq. (17).
TPRL ¼ Significant Voxel Number in Lesion MaskTotal Voxe Number in Lesion Mask  100%
FPRNLWM ¼ Significant Voxel Number in NonLesion WMTotal Voxe Number in nonLesion WM  100%
ð17Þ
3. Results
3.1. Monte Carlo simulation
From theMC simulations, it is clear that a high sensitivity can be ob-
tained by all test statistics for a simple linear trend (Fig. 3(a) and (b))
with the exception of Test Statistic QM1, which tested the signiﬁcanceoposed test statistics. TPRL and FPRNLWM calculated using each test statistic by Eq. (17) are
Fig. 8. This patient had two newgadoliniumenhancing lesions visible in this slice on the post contrast T1 images at baseline and resolved in the follow-up3-month scan and 6-month scan.
One subtle peripheral enhancing lesion (blue arrows)was within themedial aspect of the occipital horn of left lateral ventricle in the left posterior temporal area. Another one lesion (red
arrows)was located in the right subcortical temporal area (near the occipital horn of right lateral ventricle). Both lesions demonstrate hyperintensity on FLAIR image at baseline, with both
the size of the lesions and degree of FLAIR hyperintensity gradually lessened in the follow-up scans, which suggested a stable state.
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a simple linear regression model, yielded the highest statistical power.
As a side note, while the quadratic model (Eq. (9)) includes the linear
model (Eq. (8)) as a special case, Test Statistic QM2 also summarizes
the variance explained by the linear component in Eq. (9). However,
Test Statistic QM2 is not as “sharp” as Test Statistic LM because Eq. (9)
has one more unknown parameter (the quadratic term) to estimate
therefore it is not as efﬁcient as the simple linear model.
As for the quadratic model (Fig. 3(c) and (d)), a high sensitivity can
be obtained by all test statistics except for Test Statistic LM, which was
the estimated slope for simple linear regression. Both Test Statistic
QM1 and QM2, which were designed speciﬁcally for the quadratic
model, yielded slightly superior performance than the other test statis-
tics. The differences in results between different test statistics were re-
duced with the increasing sample size and effect size. For instance, a
disease progressed with a fast rate (e.g. with a relatively large effect
size change at each time point) will yield a higher detection sensitivity
than a disease progressed with a slow rate (e.g. with a relatively small
effect size change at each time point).Fig. 9. Signiﬁcant voxels detected for FA (marked bymagenta dots) using iSPREADwith three p
listed in Table 3.3.2. Human in vivo data
3.2.1. MS patient 1
This patient had an active lesion in the posterior limb of the right in-
ternal capsule visible on the post contrast T1 images at baseline and fad-
ing over time in the follow-up scans (Figs. 4–5).
All ﬁve proposed test statistics were able to achieve an average TPRL
of 88.10% and FPRNLWM of 0.07%, with a slightly decreased sensitivity
achieved by Test Statistic QM1 (Table 1). While themodel-free test sta-
tistics (Test Statistic MF1 and Test Statistic MF2) were able to control
the FWER at a reasonable rate, with an average FPRNLWM of 0.16%, it is
clear that test statistics based on a general linear model (Test Statistics
LM, QM1 and QM2) were able to control the false positive even better,
with an average FPRNLWM of 0.009%. FP voxels due to mis-registration
and atrophy were largely suppressed. This was not obvious with simu-
lated data because therewere no such effects asmis-registration and at-
rophy that will potentially cause the FPs. Due to limitation of the
proposed linear model, which could only accounts for majority of the
variations within the disease area across time, a slight decrease inroposed test statistics. TPRL and FPRNLWM calculated using each test statistic by Eq. (17) are
Fig. 10. This patient had one new gadolinium enhancing lesions visible in this slice on the post contrast T1 images at baseline (ﬁrst column, marked by red arrow) and resolved in the
follow-up scans. The enhancing lesion was located in the right splenium of the corpus callosum extending to the right major forceps area and shown as hyperintensity on the FLAIR
image at baseline, and gradually lessened both in size and intensity in the follow-up scans.
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on a general linear model compared to the model-free test statistics.
3.2.2. MS patient 2
This patient had an active lesion around the atrium of the left lateral
ventricle visible on the post contrast T1 images at 6 month from base-
line and resolved later (Figs. 6–7).
It can be seen from the results that while all test statistics could
achieve an average TPRL of 80.78%, the test statistics based on a linear re-
gression model yielded much lower FPs (0.07% vs. 2.32%), and had a
higher ability to control the FWER (Table 2). Speciﬁcally, the average
TPRL obtained by themodel-free test statistics was 90.58% and the aver-
age FPRNLWM was 2.32% compared to an average TPRL of 74.24% and an
average FPRNLWM of 0.07% obtained by the test statistics based on a lin-
ear regression model.
3.2.3. MS patient 3
This patient had three lesions located in two different slices; results
from iSPREAD are shown in Figs. 8–9 for one slice and Figs. 10–11 for the
other slice.
iSPREAD was able to detect all lesions with a very high sensitivity.
Compared to the gold standard lesion masks, lesions were detected
with anaverage TPRL of 88.10% and FPRNLWMof 2.15% for the two lesions
on one slice in Fig. 9; an average TPRL of 93.19% and FPRNLWM of 2.15%
for the lesion on the other slice in Fig. 11 (Table 3 and Table 4). SinceFig. 11. Signiﬁcant voxels detected for FA (marked bymagenta dots) using iSPREADwith three p
listed in Table 4.only three scans available in this longitudinal study, only the model-
free Test Statistics MF1, MF2 and Test Statistic LM (based on a simple
linear model) were applied to test the localized temporal changes.
4. Discussion
In this study, a nonparametric statistical method comprised of two
types of voxel-based statistics that helps in detecting subject-speciﬁc
longitudinal changes in a serial DTI data is presented. Speciﬁcally, both
the model-free voxel-based test statistics and the test statistics based
on a general linearmodelwere applied in the proposed statisticalmeth-
od to test against the null hypothesis of zero differences occurring be-
tween groups across time. While a high sensitivity and accuracy was
obtained by the ﬁve proposed speciﬁc voxel-wise statistics belonging
to the two types respectively, a signiﬁcant improvement in speciﬁcity
while including the prior information of the disease evolution. This indi-
cates the possibility of differentiating the relative contributions of ana-
tomical differences due to image mis-registration, atrophy (False
positives) and differences in tissue compositions within a presumably
homogeneous structure (True positives, e.g. lesion, tumor, normal
appearing white matter). This statistical method is an extension of pre-
viously presented SPREAD/iSPREADmethod, as well as an independent
statistical framework that can be applied to a variety of longitudinal
studies using carefully designed test statistics to help detect subject-
speciﬁc local changes within the brain.roposed test statistics. TPRL and FPRNLWM calculated using each test statistic by Eq. (17) are
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for analysis of data with low degrees of freedom to avoid noisy statistic
images (Nichols and Holmes, 2002). However, aside from their numer-
ous applications in the ﬁeld of fMRI, their applications in longitudinal
studies are sparse. Two major disadvantages of permutation-based
methods prohibit their wide use; one is the computation burden they
impose, the other is the need for sufﬁcient scans in an experiment to
give an enough number of possible labelings for generating the empiri-
cal null distribution (Holmes et al., 1996). While the ﬁrst one is partially
solved by the fast developing power computing technology, the second
one can be addressed by the previously proposed SPREAD/iSPREAD
method.
In most cases, the motivation that drives a longitudinal study is the
alternative hypothesis that there exist temporal changes between
scans at different time points; the problem then comes to which test
statistic is most informative in terms of identifying localized changes.
Two types of test statistics were herein proposed and tested in this
study. The ﬁrst type, whichmeasures the intra-subject variability across
time, is a natural extension of the test statistic used in iSPREAD for
pairwise comparison. As a model-free test statistic, it requires no prior
information about the disease evolution. However, such test statistics
are very sensitive to registration errors or anatomical differences be-
tween the scans, therefore were not able to distinguish between signif-
icant voxels caused by pathological changes (True Positives) and
anatomical differences due to atrophy or image registration error
(False positives). The general linear model used in the second type of
test statistics is similar in spirit to those used in parametric methods,
but without the need for a parametric assumption of measurement er-
rors. For the general linear model, it is very crucial to devise the design
matrix according to the speciﬁc longitudinal study to reﬂect the disease
evolution model. Both the simple linear model and quadratic model
were chosen in this study to account for the temporal effects of the le-
sion progression. Themodels chosen in this studywere simple, intuitive
and easy to implement, which can depict a large number of white mat-
ter integrity changes in longitudinal studies.
The effectiveness of the proposed statistical method was validated
by both simulation data and human in vivo brain data. For simulation
data, while model-free test statistics (Test Statistic MF1 and MF2)
were able to detect changes in lesion progressions with a high sensitiv-
ity and accuracy, Test Statistic LM, QM1 and QM2 were most useful
when the lesion progression followed a speciﬁc model. Moreover, it is
clear that when the disease progression model followed a speciﬁc
model, the test statistics designed accordingly would have a higher sta-
tistical power than model-free test statistics. Differences between dif-
ferent test statistics were most signiﬁcant when the effect size and
sample size were small, and reduced with an increasing sample size
and effect size.
For the MS patients chosen in this study, take the ﬁrst two MS pa-
tient as examples, while all ﬁve test statistics could detect longitudinal
changes in lesion evolution with an average TPRL of 87.31%, test statis-
tics based on a linear model had the ability to control the FWER at a rel-
atively low rate (with a FPRNLWM of ~0.04%) compared to an average
FPRNLWM of ~1.24% obtained from model-free test statistics. FP voxels
due to mis-registration, atrophy, partial volume and random scan vari-
ations were largely suppressed when the lesion progression model
could be speciﬁed explicitly. Compared to the model-free test statistics,
the advantage of integrating the speciﬁc lesion progression model was
clear. Unlike typical independent and identically distributed (i.i.d)
Gaussian noise, the effect of underlying anatomic differences caused
by mis-registration, atrophy, etc., are spatially smooth thus will not be
ﬁltered out by spatial regression. These artifacts increase the total vari-
ation and drive up model-free test statistics, which in turn inﬂate type I
error. However, these artifacts are in general speciﬁc to each scan and
do not follow any speciﬁc disease progression model. By imposing a
speciﬁc model of a true signal, these artifacts will be largely canceled
out in the temporal direction, which reduces the type I error as a result.It is worth pointing that for the two model-free test statistics, Test
Statistic MF2 uses the image at the ﬁrst time point as the baseline
image while the Test Statistic MF1 uses the time average image for
this purpose. Averaging images in the temporal direction reduces vari-
ability, therefore the within-group variation measured by Test statistic
MF2 is larger than Test statistic MF1, which can inﬂate the type I error
(false positives) obtained from Test statistic MF2 as compared to that
from Test statistic MF1. This is the reason why there were usually
more FPs in the results calculated from Test Statistic MF2 than that of
Test Statistic MF1 for MS patients.
Despite its advantage of better FP control with a high accuracy with
the general linear model, there are two major limitations with its use.
First and foremost, in order to devise the design matrix in the general
linear model for a speciﬁc study, prior information about the disease
progression is desirable. This is similar to the general linear model
used in fMRI; the design matrix should be devised according to the ex-
periment design. Moreover, in order to accurately model the disease
progression, an accurate model should be considered. Both the simple
linear model and quadratic model are rough approximation of the tem-
poral changes in FA/MD. The consequence of a lack of ﬁt is usually a de-
crease in detection sensitivity. As showed in the results, due to
limitations of the proposed linear model, which could only account for
the majority of the temporal variations within the disease area across
time but not all, a slightly decreased sensitivity were obtained by test
statistics using a general linear model compared to the model-free test
statistics, with a TPRL of 92.17% for the model-free test statistics versus
a TPRL of 83.35% for the test statistics based on a general linear model.
A more precise and robust time series regression model is therefore
needed to accurately examine the localized temporal changes in a longi-
tudinal study and the test statistics could be designed accordingly. How-
ever, this is not easy for a voxel-based method as the temporal change
trendsmay vary within disease area. Fortunately, there are many previ-
ous fMRI studies we can refer to (Friston et al., 1994; Bullmore et al.,
1996). Moreover, when a speciﬁc drug effect/disease evolution is of in-
terest; such effect can be easily detectedwith corresponding designma-
trix, avoiding the disruption of other “unwanted” signals. The second
limitation lies in situations when dealing with data of low degrees of
freedom. Although the iSPREADmethod greatly reduces the granularity
of permutation andmakes the permutation-basedmethod feasiblewith
data of low degrees of freedom, the multiple regression still needs the
number of data points NNk+1, where k is the number of variables.
Since the degrees of freedom for a multiple regression is N−k−1, as
the number of data points decreases, the ability to test themodel erodes
accordingly. Therefore, the simple linear model requires at least three
scans, one at each time point and evenmore scans are needed for a qua-
dratic model. However, neither of these limitations mentioned above
are speciﬁc to this approach, but rather are caused by the inherent char-
acteristic of the methodology.
The current statistical framework can be improved in at least two as-
pects. In iSPREAD, a nonlinear diffusion ﬁltering method was used to
preserve the correlation of the heterogeneous spatial structure and
greatly improve the statistical power. For a longitudinal study, the
data can be seen as 4D, with the fourth dimension being the time series.
In that sense, a 4D ﬁltering method can be applied to preserve the cor-
relation between neighboring voxels in the temporal direction, which
is expected to further promote the statistical power of the method.
However, in the case of longitudinal study with low degrees of freedom
(with few time points available), this needs more careful consideration.
The proposed statistical method provides a novel and simple way of
depicting subject-speciﬁc localized temporal changes, and is especially
suitable for datasets with low degrees of freedom. However, the appli-
cation for this study is not restricted to investigating lesion evolution,
but also for detecting longitudinal changes due to aging, drug effects
or other neurodegenerative diseases. The proposed statistical method
can be easily generalized to include a broad spectrum of longitudinal
studies as well as readily applied to other imaging applications such as
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extension of this study to include more test statistics according to the
different lesion evolutionmodels. Although the voxel-wise test statistics
tend to be more sensitive and appropriate to identify focal differences
(e.g. lesion, tumor) between groups, global summary statistics are usu-
ally used to identify diffuse changes between groups (Nichols and
Holmes, 2002). Therefore, different choices of global test statistics
such as different norms can be used in the presence of diffuse changes
within the brain (e.g. mild traumatic brain injury) to give the re-
searchers information regarding the severity of the brain injury, which
merits further investigation.
5. Conclusion
We have presented a permutation-based voxel-wise whole brain
analysis method as an extension of SPREAD/iSPREAD that facilitates de-
tecting longitudinal changes in serial DTI studies. This method can ob-
tain a high statistical power even with limited scans available, and
thus is very suitable for longitudinal studies with low degrees of free-
dom. Themethod described is shown to be accurate and able to achieve
a high sensitivity while controlling FWER at a relatively low rate when
the test statistic was designed according to the disease progression
model being investigated. The proposed framework can be easily gener-
alized to accommodate a variety of longitudinal studies using carefully
designed test statistics, whichwill greatly increase the scope of analysis
methods available for longitudinal studies at an individual level.
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